{"nct_id":"NCT05171816","title":"Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-06-24","start_date_type":"ACTUAL","primary_completion_date":"2024-01-22","primary_completion_date_type":"ACTUAL","completion_date":"2026-04-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}